Company intelligence / Profile preview

Neuroversion

Anchorage, Alaska, United Statesme-pedia.org ↗

Ownership: Private
Development stage: Clinical

Overview

Neuroversion is an active interventional pain management clinic based in Alaska. The clinic provides comprehensive care for chronic pain using interventional procedures, medication-assisted therapy for opioid use disorder, and multimodal approaches. They have published research on interventions for Long COVID, ME/CFS, and POTS and received a Ramsay Research Grant to support their work[1].

Therapeutic areas: PsychiatryCardiovascularNeurologyInfectious Diseases
Modalities: DeviceSmall moleculeBehavioral therapyMedication-assisted therapy
Industry: Academic Hospital/University/Research

Partnerships

No major pharmaceutical or biotech partnerships identified.

Beyond the preview

Go deeper on Neuroversion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroversion.

Explore the full profile